To order EarlyCDT-Lung select the geographic region of your choice by clicking on the relevant button above

If you represent a medical laboratory or a medical diagnostics distributor and you are interested in becoming a distributor of EarlyCDT-Lung, please complete the form or contact us at earlycdt@oncimmune.co.uk or +44 (0)115 8231869.

Physicians in USA can order EarlyCDT-Lung here.

The following distributors are currently offering the EarlyCDTLung test in Asia

For any enquiries regarding the following information, please email earlycdt@oncimmune.co.uk

Hong Kong

AceCGT Diagnostic Limited is a leading clinical diagnostic laboratory specializing in molecular diagnosis and early cancer detection. Please visit: http://www.acecgtdiagnostic.com/LungCDT/index.html for more information, or telephone +(852) 3979 3200.


Dow Biomedica is a distributor of diagnostic products, specialising in molecular diagnostics, immunology, microbiology and QC materials.

Dow Biomedica 3, 5, 6F, Dow Bldg., 29 Yangsan-ro, Songpa-gu, Seoul, 05771, Korea
Tel: 82-2-2201-3602
Email: info@dowbiomedica.co.kr


Invision Biotech
Tel: +886 2653 5955
E-mail: sales@ivsbiotech.com


Janesis Bioscience Pte Ltd, Business Suite Unit 9, Blk 211 Henderson Crescent, #14-02
Singapore 159552

If you are interested in becoming a distributor of EarlyCDTLung please complete the form or contact us at earlycdt@oncimmune.co.uk or +44 (0)115 8231869.

The EarlyCDTLung test can be ordered by physicians or by patients from our accredited distributors in the UK

Please note that EarlyCDT-Lung is only available privately, not through the National Health Service (NHS).  Patients will be required to pay for the test.


The EarlyCDT-Lung test needs to be provided under medical supervision. Patients should discuss EarlyCDT-Lung test with their family doctor or Specialist / Consultant who may order the test via The Doctors Laboratory.

Patients can also have EarlyCDT-Lung test via the LungCheck service provided by Lung Health UK. This service offers patients the required medical expertise and follow up needed. LungHealth UK is regulated by the Care Quality Commission.


To get the LungCheck service visit https://www.lunghealthuk.com/screening-services/lung-cancer-diagnosis or call 0800 085 0228.


Physicians can order EarlyCDT-Lung test from The Doctors Laboratory (TDL) which is the largest independent provider of diagnostic pathology services in the UK. TDL’s laboratories are CPA accredited in all disciplines. Please visit http://www.tdlpathology.com/ for more information about TDL.

Physicians, please contact TDL (http://www.tdlpathology.com/) on 0207 307 7343 or by email to earlyCDTLung@tdlpathology.com for information about taking and sending samples for EarlyCDT-Lung. TDL will provide you with postal packs or advise on local sample taking, or courier collection arrangements, as needed. Please ensure that your letter of referral, or your completed request form, is enclosed with the sample, confirming your details.

For information, or to order pathology packs, please telephone 0207 307 7343 or email earlyCDTLung@tdlpathology.com.

If you are interested in becoming a distributor of EarlyCDTLung please complete the form or contact us at earlycdt@oncimmune.co.uk or +44 (0)115 8231869.


The following Consultants, available for private referrals, know specifically about EarlyCDT-Lung and are familiar with recommended follow-up procedures. Please feel free to use other Consultants as you see fit:

  • Prof Sam Janes, Professsor of Respiratory Medicine. (020 7034 8164). Professor Janes is a Consultant in Respiratory Medicine at University College London Hospitals NHS Foundation Trust and the lead clinician for lung cancer across North Central and North East London. He is active in research and is lead investigator on several lung trials.
  • Dr Pallav Shah, Consultant Physician in Respiratory Medicine. (020 7351 8021). Dr Shah is the Lead Clinician for lung cancer services at Royal Brompton Hospital and the Chelsea & Westminster Hospital, as well as Honorary Consultant Physician to the Royal Marsden Hospital and the Royal Hospital Chelsea, London.

If you are a Consultant and would like to be included in this list, or for more information, then please contact earlycdt@oncimmune.co.uk.

The following distributors are currently providing access to the EarlyCDTLung test in Europe and the Middle East

Physicians and Patients should contact distributors directly.


Oehlenschlægersvej 22
5230 Odense M
Tel: +45 40 35 05 50
Email: info@lablab.dk
Web: www.lablab.dk


Tarvand Sina Headquarters
Address:Unit.1, first floor, Matin administrative buildings, Sarlat alley,Tayeb st, Isfahan, Iran
Zip code:  81367-33463
Tel: 0098-31-32363615
Fax: 0098-31-32335169

E-mail :   info@tstlab.com


Best Med Opinion Ltd is a leading provider of second opinions, clinical services and advanced medical diagnostics in Israel and several other countries, working with insurance companies, large organizations and private patients.  Best Med Opinion Ltd. has developed a network of specialty providers in the U.S. and other countries to assist physicians and patients in ensuring all clinical options are known and explored before a particular course of treatment is selected.

For further information on Best Med Opinion Ltd. and the EarlyCDT-Lung test, please email eran@best-med-opinion.com or call 03-5117157.


Diuvita Diagnostics AS
Org nr. 998509009 mva
Bukken Bruse 8
3055 Krokstadelva
Tlf.:      +47-90155591
E-post: post@diuvita.no


Adam Rusin – Business Development Manager
Early Cancer Diagnostics / EarlyCDT-Lung
+48 691 951 222


Sabartech S.L.
Hospital U. y P. La Fe, Torre A, Planta 7ª
Av. Fernando Abril Martorell, 106
46026 Valencia


XboXLab AB
Svampgatan 2,
573 43 Tranås


Biruni Laboratories
Tugay Tegin, Vice President
Email: ttekin@biruni.com.tr

If you are interested in becoming a distributor of EarlyCDTLung please complete the form or contact us at earlycdt@oncimmune.co.uk or +44 (0)115 8231869.


Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept